Items where authors include "Brightling, CE"

Export as [feed] Atom [feed] RSS
Jump to: Article
Number of items: 9.

Article

Stewart, I orcid.org/0000-0002-1340-2688, Jacob, J orcid.org/0000-0002-8054-2293, George, PM et al. (75 more authors) (2023) Residual lung abnormalities following COVID-19 hospitalization: interim analysis of the UKILD post-COVID study. American Journal of Respiratory and Critical Care Medicine, 207 (6). pp. 693-703. ISSN 1073-449X

McAuley, HJC, Evans, RA, Bolton, CE et al. (34 more authors) (2023) Prevalence of physical frailty including risk factors up to one year after hospitalisation for COVID-19 in the UK: a multicentre, longitudinal cohort study. EClinicalMedicine, 57. 101896. ISSN 2589-5370

Evans, RA, Leavy, OC, Richardson, M et al. (1003 more authors) (2022) Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study. The Lancet Respiratory Medicine, 10 (8). pp. 761-775. ISSN 2213-2600

Evans, RA, McAuley, H, Harrison, EM et al. (51 more authors) (2021) Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study. The Lancet Respiratory Medicine, 9 (11). pp. 1275-1287. ISSN 2213-2600

Evans, RA, McAuley, H, Harrison, EM et al. (51 more authors) (2021) Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study. The Lancet Respiratory Medicine, 9 (11). pp. 1275-1287. ISSN 2213-2600

Wild, JM, Porter, JC, Molyneaux, PL et al. (51 more authors) (2021) Understanding the burden of interstitial lung disease post-COVID-19: the UK Interstitial Lung Disease-Long COVID Study (UKILD-Long COVID). BMJ Open Respiratory Research, 8 (1). e001049. ISSN 2052-4439

Abani, O orcid.org/0000-0003-2209-9956, Abbas, A, Abbas, F et al. (6346 more authors) (2021) Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 397 (10285). pp. 1637-1645. ISSN 0140-6736

John, C, Reeve, NF, Free, RC et al. (25 more authors) (2019) Corrigendum to: Cohort profile: Extended Cohort for E-health, Environment and DNA (EXCEED). International Journal of Epidemiology, 48 (5). p. 1734. ISSN 0300-5771

John, C, Reeve, NF, Free, RC et al. (25 more authors) (2019) Cohort Profile: Extended Cohort for E-health, Environment and DNA (EXCEED). International Journal of Epidemiology, 48 (3). 678-679j. ISSN 0300-5771

This list was generated on Sat May 4 08:48:25 2024 BST.